A Single-center, Randomized, Open-label, Crossover Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435.
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Fosdevirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2010 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.
- 15 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.